The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences

Topic: Brain proteins, microglia and lab models

Plain-language summary

Transcriptional regulation of the gene encoding the amyloid precursor protein (APP) may play an important role in the formation of the amyloid depositions observed in Alzheimer disease and Down syndrome patients. To determine the promoter sequence requirements for the expression of the APP gene, we constructed plasmids containing different parts of the APP gene promoter fused to the bacterial chloramphenicol acetyl transferase (CAT) gene. Transfection of these constructs into Hela and PC12 cells revealed the presence of two blocks of regulatory sequences in the APP promoter. One block extending from about -600 to -460 bp acts as a positive regulator as its removal results in a substantial decrease in promoter activity. A second block of sequences extending from -450 to -150 bp acts like a negative regulator. We have also observed that a 38 mer synthetic oligonucleotide encompassing the region -489 to -452 of the APP promoter stimulated the activity of the heterologous TK promoter, suggesting that this region may be part of an enhancer-like element. In addition, our results suggest that the effects of various APP promoter domains on its activity may be cell specific.

@article{lahiri1991-1851527,
  author  = {Lahiri, D. K. and Robakis, N. K.},
  title   = {{The promoter activity of the gene encoding Alzheimer beta-amyloid precursor protein (APP) is regulated by two blocks of upstream sequences}},
  journal = {Brain research. Molecular brain research},
  year    = {1991},
  doi     = {10.1016/0169-328x(91)90009-m},
  pmid    = {1851527},
  url     = {https://doi.org/10.1016/0169-328x(91)90009-m}
}

Key findings

• Transfection of these constructs into Hela and PC12 cells revealed the presence of two blocks of regulatory sequences in the APP promoter.
• One block extending from about -600 to -460 bp acts as a positive regulator as its removal results in a substantial decrease in promoter activity.
• We have also observed that a 38 mer synthetic oligonucleotide encompassing the region -489 to -452 of the APP promoter stimulated the activity of the heterologous TK promoter, suggesting that this region may be part of an enhancer-like element.
• In addition, our results suggest that the effects of various APP promoter domains on its activity may be cell specific.

Why it matters

In Hela and PC12 cells, the study identified two blocks of regulatory sequences in the APP gene promoter, one acting as a positive regulator and one as a negative regulator. This is laboratory work on how the APP gene is controlled, not a treatment or prevention finding.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1016/0169-328x(91)90009-m
• PubMed: 1851527
• Original source →

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Related

Studies in the library that share something with this one. The line above each title says what.

• same condition: Down syndrome; same outcome: amyloid or tau burden The striatum is an early, accurate indicator of amyloid burden using [11C]PiB in Down syndrome: comparison of two radiotracers Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024-12-06 · usefulness score 63/100
• same condition: Down syndrome; same outcome: amyloid or tau burden The striatum is an early, accurate indicator of amyloid burden using [11C]PiB in Down syndrome: Comparison of two radiotracers Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025-04-01 · usefulness score 60/100
• same condition: Down syndrome; same outcome: amyloid or tau burden Lecanemab and Vascular-Amyloid Deposition in Brains of People With Down Syndrome JAMA neurology · 2024-10-01 · usefulness score 53/100
• same condition: Down syndrome; same outcome: amyloid or tau burden Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome Archives of pathology & laboratory medicine · 2001-04-01 · usefulness score 51/100
• same condition: Down syndrome; same outcome: amyloid or tau burden Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation Neurobiology of Disease · 1996-02-01 · usefulness score 51/100
• same condition: Down syndrome; same outcome: amyloid or tau burden Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report Alzheimer's & dementia (Amsterdam, Netherlands) · 2019-11-25 · usefulness score 50/100

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

• The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor Nature · 1987-02-01 · usefulness score 58/100 · Disease mechanisms
• Amyloid plaque core protein in Alzheimer disease and Down syndrome Proceedings of the National Academy of Sciences of the United States of America · 1985-06-01 · usefulness score 56/100 · Down syndrome and Alzheimer's
• Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides Proceedings of the National Academy of Sciences of the United States of America · 1987-06-01 · usefulness score 45/100 · Down syndrome and Alzheimer's

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

• Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer's neurodegeneration Journal of neural transmission. Supplementum · 1999-01-01 · usefulness score 43/100 · Down syndrome and Alzheimer's

Related studies in Down syndrome and Alzheimer's from nearby years

• Psychiatric disorders in persons with Down syndrome The Journal of nervous and mental disease · 1991-10-01 · usefulness score 48/100
• Expression of the amyloid precursor protein gene in mouse oocytes and embryos Proceedings of the National Academy of Sciences of the United States of America · 1991-03-01 · usefulness score 39/100
• The predominant form of the amyloid beta-protein precursor in human brain is protease nexin 2 Proceedings of the National Academy of Sciences of the United States of America · 1991-11-01 · usefulness score 39/100
• APP717, APP693, and PRIP gene mutations are rare in Alzheimer disease American journal of human genetics · 1991-09-01 · usefulness score 38/100

Also tagged “precursor”

1,337 studies in the library carry the topic tag “precursor”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,337 tagged studies.

• Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer's disease Alzheimer's research & therapy · 2023-09-20 · usefulness score 67/100 · Treatments
• Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB) Autophagy · 2021-02-23 · usefulness score 44/100 · Biomarkers
• Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid β peptide The Journal of neuroscience : the official journal of the Society for Neuroscience · 2012-10-01 · usefulness score 50/100 · Caregiving

Studies sharing this one's topic tags

• APOE4 homozygosity represents a distinct genetic form of Alzheimer's disease Nature Medicine · 2024-05 · usefulness score 61/100 · shares: precursor, apoe
• APOE2 is associated with longevity independent of Alzheimer's disease eLife · 2020-10-19 · usefulness score 65/100 · shares: precursor, apoe
• Retraction Note: A specific amyloid-beta protein assembly in the brain impairs memory Nature · 2024-06-24 · usefulness score 16/100 · shares: precursor, apoe
• NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice Nature · 2012-12-19 · usefulness score 62/100 · shares: precursor, apoe
• Impact of learning APOE genotype on cognitively unimpaired adults: a pre-screening cohort study of the Alzheimer's Prevention Initiative Generation Study 1 The Lancet Healthy Longevity · 2025-11-27 · usefulness score 63/100 · shares: precursor, apoe

Similar studies

• Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease 2006 · Down syndrome and Alzheimer's
• The Alzheimer amyloid precursor protein (APP) and FE65, an APP-binding protein, regulate cell movement 2001 · Risk genes beyond APOE
• Expression of APP in brains of transgenic mice containing the entire human APP gene 1993 · Down syndrome and Alzheimer's
• MicroRNA regulation of Alzheimer's Amyloid precursor protein expression 2009 · Risk genes beyond APOE
• Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus 1987 · Down syndrome and Alzheimer's
• A nuclear factor-binding domain in the 5'-untranslated region of the amyloid precursor protein promoter: implications for the regulation of gene expression 2010 · Down syndrome and Alzheimer's

More on Down syndrome and Alzheimer's

• A review that covers this ground beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease Trends in neurosciences · 1993-10-01 · usefulness score 36/100
• Newest in this subject Adverse life experiences, mood symptoms, and quality of life in adults with down syndrome Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026-11-12 · Peer-reviewed · usefulness score 52/100
• Newest in this subject Single-cell and spatial transcriptomics of cellular heterogeneity in Alzheimer disease Nature reviews. Neuroscience · 2026-11-06 · Peer-reviewed · usefulness score 43/100

See all studies in Down syndrome and Alzheimer's →